TCL Archive FDA advisors vote against recommending Johnson & Johnson’s Zarnestra for treatment of AML in the elderly. By Cancer History Project May 6, 2005
TCL Archive Cancer research poised for a “platinum age” as a “golden age” ends, NCI director tells AACR annual meeting. By Cancer History Project April 29, 2005
TCL Archive NCI Closes Iressa Trial For NSCLC When Data Indicate No Survival Benefit By Cancer History Project April 29, 2005
TCL Archive U.S., Canada Begin ExCel Trial To Evaluate Aromasin For Breast Cancer Prevention By Cancer History Project April 29, 2005
TCL Archive Also FDA clarifies data requirements for phase I IND applications. By Cancer History Project April 29, 2005
TCL Archive Preoperative Drug Combo Benefits HER-2 Breast Cancer By Cancer History Project April 29, 2005
TCL Archive Combination Radiation/Vaccine May Benefit Some Patients By Cancer History Project April 29, 2005
People Paula Charuhas Macris, the world’s first BMT dietitian, celebrates 37 years of nourishing care By Fred Hutch
People One Brother’s Love: A baseball legend, his brother, and the origin of Fred Hutch Cancer Center By Fred Hutch
